Early Detection of Ovarian Cancer

Early Detection of Ovarian Cancer

Despite advances in therapy, ovarian cancer remains the most deadly of the gynecological cancers. Less than 30% of women with advanced stage disease survive long-term. When diagnosed in stage I, up to 90% of patients can be cured with conventional surgery and chemotherapy. At present, only 25% of ovarian cancers are detected in stage I due, in part, to the absence of specific symptoms and to la...

EPIC Early Detection of Ovarian Cancer.

CA125 dominated performance for ovarian cancer early detection among four serum biomarkers evaluated in EPIC study prediagnostic serum, rising on average 3 years prior to detection. Adding HE4 provided only marginal improvement. This natural history supports annual testing for early detection and highlights the importance of biomarker discovery complementing CA125. Clin Cancer Res; 22(18); 4542...

Early Detection Biomarkers for Ovarian Cancer

Despite the widespread use of conventional and contemporary methods to detect ovarian cancer development, ovarian cancer remains a common and commonly fatal gynecological malignancy. The identification and validation of early detection biomarkers highly specific to ovarian cancer, which would permit development of minimally invasive screening methods for detecting early onset of the disease, ar...

Early Detection of Breast Cancer among Women in Mazandaran, Iran

Background and purpose: After lung cancer, breast cancer, among the prevalent cancers of the world is of the most widespread disease among women. It is the most common cause of mortality among women. This study aimed to analyze the results using breast cancer screening methods among women over 20 years old. Materials and methods: The present study is a cross-sectional-descriptive research. The ...

National Ovarian Cancer Early Detection Program A National Cancer Institute-Supported Ovarian Cancer Program